Sign Up to like & get
recommendations!
0
Published in 2021 at "Japanese Journal of Ophthalmology"
DOI: 10.1007/s10384-020-00796-3
Abstract: To assess the 12-month efficacy and safety of fixed-combination brimonidine tartrate 0.2%/timolol maleate 0.5% (FCBT) with or without bimatoprost 0.01% (BIM) in primary open-angle glaucoma (POAG), including normal-tension glaucoma (NTG). Prospective, multicenter, open-label study. FCBT…
read more here.
Keywords:
safety;
fcbt;
glaucoma;
iop ... See more keywords